ANDRUS Selects Streamline s Integrated SmartCare Electronic Health Record To Meet Their Current And Future Organizational Needs
OAKBROOK TERRACE, ILL. (BUSINESS WIRE)
After a diligent and detailed evaluation process, ANDRUS of Yonkers, NY has selected Streamline’s SmartCare for their next EHR application. Their main desire was to consolidate their EMR, EHR, incident database, and residential tracking all into one comprehensive software platform. It was determined that SmartCare met all their needs while allowing complete access to the EHR data for ease of reporting in the future.
Jason Honecker, Vice President and Chief Operating Officer at ANDRUS said, “ANDRUS is excited to have Streamline as a partner. We look forward to integrating the all-inclusive SmartCare platform into our operation.”
E-Prescribing Market Size to Reach Revenues of over USD 3 Billion by 2026 - Arizton
The e-prescribing market is expected to grow at a CAGR of over 21% during the period 2020-2026.
Key Highlights Offered in the Report:
The global e-prescribing market is likely to witness an incremental growth of over USD 2 billion and an absolute growth of above 217% during the forecast period.
E-prescribing for controlled substances (EPCS) segment is likely to witness an absolute growth of over 265%, growing at a CAGR of around 24% during the forecast period.
The web & cloud-based segment is expected to grow with the highest CAGR of nearly 22% and absolute growth of over 226% during the forecast period.
Despite the shifting attitude toward cannabis around the globe and the easing of international restrictions, the merit of the endocannabinoid system and cannabis-related medicine are still largely misunderstood, or worse, ignored. This regularly causes an adverse impact for no good reason.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global health information exchange market is expected to reach USD 2.0 billion by 2025 from USD 1.1 billion in 2020, at a CAGR of 12.2%.
Growth in this market can be attributed to factors such as growing need to curtail healthcare costs, focus on patient-centric care delivery, growing adoption of EHRs and other HCIT solutions, government initiatives for enhancing patient care and safety, government funding for healthcare interoperability. However, data privacy concerns, need for significant investments in infrastructure development and high cost of deployment, lack of true interoperable solutions are expected to hinder the market growth.
8.2.3 Wellness Hurts
8.3 Instrumentation and Automation
8.3.2 The Shrinking Machine
8.4 Diagnostic Technology Development
8.4.2 POCT/Self Testing as a Disruptive Force
8.4.3 The Genetics Play - One Test for All Known Infections
8.4.4 Antibiotic Resistance Genes - Simplifying Diagnostics
9 Molecular Dx - Infectious Disease Recent Developments
9.1 Recent Developments - Importance and How to Use This Section
9.1.1 Importance of These Developments
9.1.2 How to Use This Section
9.2 Roche to Acquire GenMark Diagnostics for $1.8B
9.3 Lucira Health Focuses on User Friendly Approach to Home Testing
9.4 Infectious Disease Dx Firm Talis Biomedical Raises $254M in IPO
9.5 Fluidigm Plans Durable Diagnostics, Clinical Business
9.6 Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M